U.S. Capital Markets Stock News

StoneCo (STNE) is back in focus after the stock fell 2.15%, lagging major indexes, as investors look ahead to the company’s August 13, 2026 earnings release. See our latest analysis for StoneCo. The recent 1-day share price return decline of 1.79% and 7-day decline of 3.52% extend a weaker short term trend for StoneCo. At the same time, the 1-year total shareholder return of 2.45% and 5-year total shareholder return decline of 76.58% point to mixed longer term outcomes around the current...

Viridian Therapeutics recently reported positive topline results from its Elegrobart REVEAL-1 phase III trial in Graves' ophthalmopathy and outlined plans to submit a Biologics License Application in early 2027. This progress, combined with the recent approval of Viridian’s LUMVOA and a pipeline that includes other emerging therapies for Graves’ ophthalmopathy, highlights the company’s growing role in this specialized autoimmune eye disease market. We’ll now examine how the positive...

Fed Chair Kevin Warsh’s move to dial back forward guidance has left markets more data driven and, at times, more jumpy. When rate clues are harder to read, many investors start to focus on stocks that have shown relatively low price swings and steadier profiles. That is where a low volatility screener can help filter the chaos. This article looks at three stocks from that list that appear positively exposed to the current policy uncertainty and recent volatility in Treasury yields, and...

Adobe, ticker NasdaqGS:ADBE, has joined a new coalition to launch the Open Source AI Cybersecurity Alliance. The alliance focuses on open source collaboration to improve cybersecurity for artificial intelligence systems. This company initiative has not been widely covered in recent Adobe news as of July 2026. Adobe is best known for its creative and digital experience software, but its role in AI has been growing across products and services. Joining the Open Source AI Cybersecurity...

Northrop Grumman stock has delivered a 62.4% gain over the past five years, yet current valuation checks and intrinsic value estimates both point to the shares trading below what the underlying cash flows imply. With market sentiment still digesting mixed shorter term returns, the question is whether the current price fully reflects the company’s long term contract and earnings profile. Over five years, Northrop Grumman has returned 62.4%, which suggests long term holders have been rewarded...

Recent analyst commentary compared Ormat Technologies with Ameresco, highlighting Ormat’s Zacks Rank of #3 (Hold) and relatively less attractive valuation metrics, alongside expectations, since realized in the past, that its upcoming quarterly report would show higher revenue but lower year-over-year earnings. Analysts had also revised Ormat’s earnings estimates upward and pointed to a high Earnings ESP and a history of topping EPS expectations, which together drew fresh attention to how...

Investors watching the latest Goldman Sachs tribunal decision on sex discrimination and unfair dismissal can see how quickly employment disputes turn into real financial and reputational costs. Human resources and employment law services sit close to this pressure point, from compliance advice to managing workplace disputes. When a £1.45mn award and critical findings on dismissal processes hit headlines, that can influence how companies think about risk management and where they spend on...

AppLovin (APP) is back in focus after fresh analyst commentary highlighted expectations for quarterly results above the company’s guidance, with particular attention on the gaming segment and sequential revenue trends. See our latest analysis for AppLovin. Recent excitement around AppLovin’s expected results sits against a weaker near term trend, with the share price down 19.91% over 30 days and 35.40% year to date. However, a 3 year total shareholder return above 10x still points to strong...

Why Stanley Black & Decker Stock Is Back in Focus After Q2 Earnings Stanley Black & Decker (SWK) moved back onto investors’ radar after second quarter results showed net income of $351.3 million and higher earnings per share, alongside a raised 2026 GAAP EPS outlook. See our latest analysis for Stanley Black & Decker. After these Q2 results and the raised 2026 GAAP EPS outlook, Stanley Black & Decker’s share price at US$93.05 sits on a year to date share price return of 21.68%. The 1 year...

Gartner stock has had a tough run over the past year, yet current valuation checks suggest the share price may now sit below what its Discounted Cash Flow (DCF) and earnings multiple signals imply for intrinsic value. Over the past 12 months the share price has fallen 51.8%, which puts recent gains into context and raises the question of whether sentiment has moved further than the fundamentals. Recent headlines around Gartner's AI forecasts and its role in shaping spending on AI...

Nexstar Media Group (NXST) is drawing attention after announcing that its Kansas stations will air a live, multi market telecast of the Democratic governor candidates' debate on July 31 across TV and digital platforms. See our latest analysis for Nexstar Media Group. The debate announcement comes as Nexstar Media Group’s recent momentum has picked up, with a 7 day share price return of 8.71% and a 30 day share price return of 10.27%, even though the year to date share price return is down...

Viatris Inc. recently received U.S. Food and Drug Administration approval for Gwyn Lo, a once-weekly low-estrogen combined hormonal contraceptive patch for women with a body mass index below 30 kg/m², supported by Phase 3 data showing contraceptive efficacy, a well-characterized safety profile and strong patch adhesion. By adding a low-dose, non-invasive, weekly contraceptive option that targets women seeking convenience and reversibility, Viatris is broadening its branded and complex...

International Paper has delivered a 33.3% gain over the past three years, yet the stock still screens as undervalued on key valuation checks, which puts the recent price moves and containerboard news in sharp focus for investors. A 33.3% return over three years suggests International Paper has already rewarded patient shareholders. The question is whether the current price still leaves room for further upside or now embeds much of that progress. Recent containerboard price increase plans and...

Investors are watching Tarsus Pharmaceuticals (TARS) ahead of its upcoming quarterly report, with expectations for a loss alongside higher revenue compared with last year and a cautious Zacks Rank of #4. See our latest analysis for Tarsus Pharmaceuticals. At a share price of US$58.52, Tarsus Pharmaceuticals has seen its share price decline 27.6% year to date, even though the 1 year total shareholder return is 46.3%. This suggests long term holders are still sitting on strong gains despite...

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...

Earlier this week, n-Lorem Foundation announced an early-stage research collaboration and exclusive global licence agreement with BioMarin Pharmaceutical to develop an investigational antisense oligonucleotide therapy for ReNU syndrome, with preclinical work underway and plans for future clinical studies. A key aspect of the deal is BioMarin’s intention to develop the medicine for broader use across the ReNU syndrome community, aiming to address an estimated 75% of cases and potentially...

Capital Clean Energy Carriers (CCEC) stock is in focus after the company reported second quarter 2026 earnings, which showed higher sales alongside slightly lower net income and earnings per share compared with the same period last year. See our latest analysis for Capital Clean Energy Carriers. At a share price of $22.72, Capital Clean Energy Carriers has logged an 8.86% 1 month share price return and an 11.32% year to date share price return. Its 1 year total shareholder return is broadly...

In July 2026, First BanCorp. reported second-quarter 2026 results showing higher net interest income of US$229.13 million and net income of US$96.15 million year-on-year, alongside lower net charge-offs of US$15.98 million, completion of a US$112.78 million share repurchase program, and affirmation of a US$0.20 quarterly dividend. Together, stronger earnings, reduced credit losses, ongoing dividends, and completed buybacks highlight how First BanCorp. is actively returning capital while...

Why CVS Health Stock Is Back On Investors’ Radar CVS Health (CVS) has drawn fresh attention ahead of its upcoming quarterly earnings report, as investors weigh upbeat expectations alongside a run of recent business updates and industry recognition. Over the past year, CVS Health stock has outperformed the broader market and delivered a total return of 75.4%. The share price closed at US$105.92 on 29 July 2026, with gains of 2.3% over the past month and 27.2% over the past 3 months. See our...

Guidance surprise puts Delta Air Lines (DAL) earnings in focus Delta Air Lines (DAL) lifted its full-year 2026 revenue, adjusted operating profit, and earnings guidance after reporting second-quarter results that topped expectations despite higher fuel costs and ongoing network adjustments. See our latest analysis for Delta Air Lines. Delta Air Lines’ 1 day share price return declined 3.49% to US$86.25. However, the 90 day share price return of 26.86% and 1 year total shareholder return of...

In late July 2026, Equifax Inc. reported second-quarter results showing higher sales of US$1,700.1 million but lower net income of US$183.9 million year-on-year, issued third-quarter 2026 guidance calling for revenue of US$1.68 billion to US$1.71 billion and EPS of US$2.15 to US$2.25, completed two fixed-income offerings totaling about US$998 million in senior unsecured callable notes, and disclosed completion of a US$1,487.36 million share repurchase program covering 7,113,801 shares. An...

Wingstop stock has fallen 61.9% over the past year, yet the current checks send mixed signals on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) approach pointing to upside while earnings based multiples screen the shares as expensive. Recent news around soft same store sales and loyalty driven promotions adds another layer to how investors may think about what a fair price for Wingstop looks like today. Wingstop is down 61.9% over the last year, which puts the...

Recently, Stephens & Co. initiated research coverage on H&R Block with an Equal-Weight rating, adding another institutional voice to the tax preparer’s analyst following. This new coverage lands after past strong earnings and guidance raised in May, potentially sharpening investor focus on the company’s defensive profile and relative valuation. Next, we’ll examine how this fresh analyst coverage and heightened visibility may influence H&R Block’s broader investment narrative. Capitalize on...